GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract 75N93022C00059AN2 THERAPEUTICS, INC.

Overview

Award facts

Net obligations
$9.24M
$9,235,577of $18.27M potential value
Outlays (paid to date)
$6.87M
$6.87M paid of $9.24M obligated$6,867,235
Period of performance
Sep 20, 2022 to Jul 31, 2027
Ends in 8 months
Modifications
11
Latest action Aug 18, 2026
Contract type
Definitive contract
PIID 75N93022C00059

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

DEVELOPMENT OF EPETRABOROLE AS A NOVEL THERAPEUTIC FOR MELIOIDOSIS AND ADDITIONAL ANTIMICROBIAL RESISTANT (AMR) BACTERIAL BIOTHREAT PATHOGENS.

Dates and value

Award date
Signed on Sep 20, 2022
Current value
$9,235,577Base and exercised options
Potential value (if all options are exercised)
$18,274,778

Obligations by fiscal year of action

  • FY2025: $456,766
  • FY2024: $3,821,365
  • FY2023: $651,041
  • FY2022: $4,306,405

Total across 4 fiscal years: $9,235,577

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 18, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationMENLO PARK, CA
UEIDD4FE2GE4L78
CAGE code822Z2
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyAN2 THERAPEUTICS INC

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Menlo Park, San Mateo County, California 94025-3069
Congressional district (place of performance)
CA-16As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost no feeS
Offers received
30

Solicitation and notices

Solicitation ID
PHS-2021-1
Solicitation date
Feb 23, 2021
Notices

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
Yes
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 20, 2022Base obligation at award: $4,306,405
Latest action
Aug 18, 2026 — Supplemental agreement (within scope)Modification P00011
Latest substantive action
Aug 18, 2026 — Supplemental agreement (within scope)Modification P00011
Actions by type
  • Base award1
  • Supplemental agreement (within scope)9
  • Option exercised2
12 actions recorded, Sep 20, 2022 to Aug 18, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
12

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2022/2022-0885-000
  • 075-2023/2023-0885-000
  • 075-2024/2024-0885-000
  • 075-2025/2025-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression